Interestingly, ALOX15B mRNA levels were described to be higher in symptomatic plaques with attributable cerebrovascular symptoms (amaurosis fugax, transient ischemic attack, or stroke) than in asymptomatic plaques (Gertow et al., 2011). This evidence concerns the gene ALOX15B and stroke disorder.